NASDAQ: TER
TERADYNE, INCCIK 0000097210 · SIC 3825 · Instruments for Measuring
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
Summary not yet generated.
TER Q2 revenue doubles to $1.33B on AI compute/memory surge; acquires MLTP
5 material changes detected. Sign up free to read the summary.
Partner
Trade TER commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 31, 2026 (period ending Jun 28, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share amount)
| Description | Three months ended June 28, 2026 | Three months ended June 29, 2025 | Six months ended June 28, 2026 | Six months ended June 29, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products | 1,191,327 | 522,657 | 2,334,298 | 1,084,614 |
| Services | 137,663 | 129,140 | 277,186 | 252,863 |
| Total revenues | 1,328,990 | 651,797 | 2,611,484 | 1,337,477 |
| Cost of revenues: | ||||
| Cost of products | 487,221 | 232,422 | 940,667 | 456,564 |
| Cost of services | 47,151 | 46,363 | 95,249 | 92,564 |
| Total cost of revenues (exclusive of acquired intangible assets amortization shown separately below) | 534,372 | 278,785 | 1,035,916 | 549,128 |
| Gross profit | 794,618 | 373,012 | 1,575,568 | 788,349 |
| Operating expenses: | ||||
| Selling and administrative | 192,520 | 157,782 | 359,257 | 315,039 |
| Engineering and development | 156,284 | 118,382 | 291,845 | 236,570 |
| Acquired intangible assets amortization | 4,972 | 3,733 | 7,196 | 8,306 |
| Restructuring and other | 3,032 | 2,372 | 6,457 | 16,887 |
| Total operating expenses | 356,808 | 282,269 | 664,755 | 576,802 |
| Income from operations | 437,810 | 90,743 | 910,813 | 211,547 |
| Non-operating (income) expense: | ||||
| Interest income | (3,182) | (4,351) | (5,604) | (9,427) |
| Interest expense | 2,964 | 805 | 6,115 | 1,600 |
| Other (income) expense, net | (5,591) | (2,270) | 1,006 | 3,790 |
| Income before income taxes and equity in net earnings of affiliate | 443,619 | 96,559 | 909,296 | 215,584 |
| Income tax provision | 66,788 | 12,260 | 128,945 | 26,804 |
| Income before equity in net earnings of affiliate | 376,831 | 84,299 | 780,351 | 188,780 |
| Equity in net earnings of affiliate | (1,946) | (5,927) | (6,557) | (11,511) |
| Consolidated net income | 374,885 | 78,372 | 773,794 | 177,269 |
| Less: Net income attributable to noncontrolling interests | 352 | — | 352 | — |
| Net income attributable to Teradyne | 374,533 | 78,372 | 773,442 | 177,269 |
| Earnings per common share attributable to Teradyne: | ||||
| Basic | 2.39 | 0.49 | 4.94 | 1.10 |
| Diluted | 2.38 | 0.49 | 4.91 | 1.10 |
| Weighted average common shares—basic | 156,470 | 159,967 | 156,440 | 160,734 |
| Weighted average common shares—diluted | 157,693 | 160,135 | 157,664 | 161,065 |
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except per share amount)
| Description | June 28, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 349,538 | 293,751 |
| Marketable securities | 5,291 | 28,247 |
| Accounts receivable, less allowance for credit losses of $2,835 and $2,410 at June 28, 2026 and December 31, 2025, respectively | 1,109,711 | 786,913 |
| Inventories, net | 403,297 | 379,552 |
| Prepayments | 468,174 | 427,564 |
| Other current assets | 30,011 | 33,273 |
| Total current assets | 2,366,022 | 1,949,300 |
| Property, plant and equipment, net | 634,839 | 562,999 |
| Operating lease right-of-use assets, net | 94,302 | 76,635 |
| Marketable securities | 162,274 | 126,256 |
| Deferred tax assets | 289,582 | 275,265 |
| Retirement plans assets | 12,140 | 12,059 |
| Equity method investment | 514,957 | 537,098 |
| Other assets | 85,774 | 71,697 |
| Acquired intangible assets, net | 101,910 | 51,271 |
| Goodwill | 663,817 | 521,019 |
| Total assets | 4,925,617 | 4,183,599 |
| LIABILITIES | ||
| Current liabilities: | ||
| Accounts payable | 383,422 | 269,185 |
| Accrued employees’ compensation and withholdings | 220,690 | 254,973 |
| Deferred revenue and customer advances | 193,840 | 153,124 |
| Other accrued liabilities | 133,399 | 111,845 |
| Operating lease liabilities | 17,258 | 19,340 |
| Short-term debt | — | 200,000 |
| Income taxes payable | 164,907 | 106,740 |
| Total current liabilities | 1,113,516 | 1,115,207 |
| Retirement plans liabilities | 151,436 | 144,874 |
| Long-term deferred revenue and customer advances | 62,985 | 50,888 |
| Deferred tax liabilities | 12,929 | 5,378 |
| Long-term other accrued liabilities | 28,569 | 7,601 |
| Long-term operating lease liabilities | 82,869 | 63,899 |
| Total liabilities | 1,452,304 | 1,387,847 |
| Commitments and contingencies (Note R) | ||
| EQUITY | ||
| Common stock, $0.125 par value, 1,000,000 shares authorized; 156,378 and 156,088 shares issued and outstanding at June 28, 2026, and December 31, 2025, respectively | 19,547 | 19,511 |
| Additional paid-in capital | 2,003,232 | 1,989,911 |
| Accumulated other comprehensive loss (gain) | 10,756 | 41,895 |
| Retained earnings | 1,403,627 | 744,435 |
| Total Teradyne shareholders’ equity | 3,437,162 | 2,795,752 |
| Equity attributable to noncontrolling interests | 36,151 | — |
| Total equity | 3,473,313 | 2,795,752 |
| Total liabilities and equity | 4,925,617 | 4,183,599 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Six months ended June 28, 2026 | Six months ended June 29, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Consolidated net income | 773,794 | 177,269 |
| Adjustments to reconcile consolidated net income from operations to net cash provided by operating activities: | ||
| Depreciation | 58,884 | 52,835 |
| Stock-based compensation | 41,964 | 32,031 |
| Equity in net earnings of affiliate | 6,557 | 11,511 |
| Losses (gains) on investments | (4,923) | (1,078) |
| Provision for excess and obsolete inventory | 8,281 | 12,347 |
| Amortization | 7,421 | 8,856 |
| Deferred taxes | (18,230) | (14,998) |
| Retirement plan actuarial losses (gains) | (157) | 127 |
| Other | 2,760 | 3,168 |
| Changes in operating assets and liabilities, net of businesses acquired: | ||
| Accounts receivable | (302,176) | 49,496 |
| Inventories | (7,852) | (23,707) |
| Prepayments and other assets | (59,621) | 30,879 |
| Accounts payable and other liabilities | 121,803 | 17,135 |
| Deferred revenue and customer advances | 50,863 | 13,056 |
| Retirement plans contributions | (3,098) | (5,576) |
| Income taxes | 57,992 | (19,625) |
| Net cash provided by operating activities | 734,262 | 343,726 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (155,439) | (114,429) |
| Acquisition of businesses, net of cash and cash equivalents acquired | (165,611) | (144,380) |
| Purchase of investment in a business | (10,030) | (5,368) |
| Purchases of marketable securities | (48,235) | (17,150) |
| Proceeds from maturities of marketable securities | 11,069 | 32,603 |
| Proceeds from sales of marketable securities | 29,615 | 8,487 |
| Net cash used for investing activities | (338,631) | (240,237) |
| Cash flows from financing activities: | ||
| Proceeds from borrowings on revolving credit facility | 350,000 | — |
| Repayments of borrowings on revolving credit facility | (550,000) | — |
| Dividend payments | (40,710) | (38,584) |
| Repurchase of common stock | (74,238) | (274,873) |
| Payments related to net settlement of employee stock compensation awards | (41,113) | (14,954) |
| Issuance of common stock under stock purchase and stock option plans | 15,101 | 14,792 |
| Net cash used for financing activities | (340,960) | (313,619) |
| Effects of exchange rate changes on cash and cash equivalents | 1,116 | (3,972) |
| (Decrease) increase in cash and cash equivalents | 55,787 | (214,102) |
| Cash and cash equivalents at beginning of period | 293,751 | 553,354 |
| Cash and cash equivalents at end of period | 349,538 | 339,252 |
| Non-cash investing activities: | ||
| Capital expenditures incurred but not yet paid: | 9,791 | 4,722 |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per share amount); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗